Nicotine protects against the dexamethasone potentiation of kainic acid-induced neurotoxicity in cultured hippocampal neurons

Brain Research

Volumn 735, Issue 2, 1996, Pages 335-338

  Semba, Jun'ichi ^a   Miyoshi, Rie ^b   Kito, Shozo ^a  

^a OPEN UNIVERSITY OF JAPAN   (Japan)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Dexamethasone; Hippocampus; Kainic acid; Neurotoxicity; Nicotine

Indexed keywords

DEXAMETHASONE; KAINIC ACID; MECAMYLAMINE; NEUROPROTECTIVE AGENT; NICOTINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FETUS; HIPPOCAMPUS; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0030574078     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00926-2     Document Type: Article

References (27)

1. [1] Akaike, A., Tamura, Y., Yokota, T., Shimohara, S. and Kimura, J., Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity, Brain Res., 644 (1994) 181-187.
2. [2] Alberch, J., Carman-Krzan, M., Fabrazzo. M. and Wise, B.C., Chronic treatment with scopolamine and physostigmine changes nerve growth factor (NGF) receptor density and NGF content in rat brain, Brain Res., 542 (1991) 233-240.
3. [3] Baron, J.A., Cigarette smoking and Parkinson's disease, Neurology, 36 (1986) 1490-1496.
4. [4] Carnes, M., Smith, J.C. and Kalin, N.H., The dexamethasone suppression test in demented outpatients with and without depression, Psychiatry Res., 9 (1983) 337-344.
5. [5] Gerlach, J.L. and McEwen, B.S., Rat brain binds adrenal steroid hormone: radioautography of hippocampus with corticosterone, Science, 175 (1972) 1133-1136.
6. [6] Horner, H.C., Packan, D.R. and Sapolsky, R.M., Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia, Neuroendocrinology, 52 (1990) 57-64.
7. [7] Hötnagl, H., Berger, M.L., Havelec, L. and Hornykiewicz, O., Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A), J. Neurosci., 13 (1993) 2939-2945.
8. 1 receptor and is dependent on NMDA stimulation, Mol. Brain Res., 23 (1994) 1-13.
9. [9] Marin, P., Maus, M., Desagher S., Glowinski, J. and Prémont, J., Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity, Neuro Report, 5 (1994) 1977-1980.
10. [10] Mattson, M.P., Acetylcholine potentiates glutamate-induced neurodegeneration in cultured hippocampal neurons, Brain Res., 497 (1989) 402-406.
11. 2+ concentration in cultured rat hippocampal neurons, Brain Res., 489 (1989) 361-364.
12. [12] Monteggia, L.M., Arneric, S.P. and Giordano, T., Nicotine effects on the regulation of amyloid precursor protein splicing, neurotrophin and glucose transporter RNA levels in aged rats, Int. J. Dev. Neurosci., 12 (1994) 133-141.
13. [13] Morens, D.M., Grandinetti, A., Reed, D., White, L.R. and Ross, G.W., Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue, Neurology, 45 (1995) 1041-1051.
14. [14] Olney, J.W., Labruyere, J., Wang, G., Wozniak, D.F., Price, M.T. and Sesma, M.A., NMDA antagonist neurotoxicity: mechanism and prevention, Science, 254 (1991) 1515-1518.
15. [15] Packan, D.R. and Sapolsky, R.M., Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity, Neuroendocrinology, 51 (1990) 613-618.
16. [16] Pang, Y., Kiba, H. and Jayaraman, A., Acute nicotine injections induce c-fos mostly in nondopaminergic neurons of the midbrain of the rat, Mol. Brain Res., 20 (1993) 162-170.
17. [17] Raskind, M., Peskind, E. and Rivard, M.F., Veith, R. and Barnes, R., Dexamethasone suppression test and cortisol and circadian rhythm in primary degenerative dementia, Am. J. Psychiatry, 139 (1982) 1468-1471.
18. [18] Reul, J.M.H.M. and De Kloet, E.R., Two receptor systems for corticosterone in rat brain; microdistribution and differential occupation, Endocrinology, 117 (1985) 2505-2511.
19. [19] Sapolsky, R.M., A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults, J. Neurosci., 5 (1985) 1228-1232.
20. [20] Sapolsky, R.M., Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels, J. Neurosci., 6 (1986) 2240-2246.
21. [21] Sapolsky, R.M., Krey, L.C. and McEwen, B.S., Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging, J. Neurosci., 5 (1985) 1122-1127.
22. [22] Sapolsky, R.M., Packan, D.R. and Vale, W.W., Glucocorticoid toxicity in the hippocampus: in vitro demonstration, Brain Res., 453 (1988) 367-371.
23. [23] Sapolsky, R.M. and Pulsinelli, W., Glucocorticoids potentiates ischemic injury to neurons: therapeutic implications, Science, 229 (1985) 1397-1399.
24. [24] Terry Jr. A.V. and Clarke, M.S.F., Nicotine stimulation of nerve growth factor receptor expression, Life Sci., 55 (1994) PL 91-98.
25. [25] Tombaugh, G.C., Yang, S.H., Swanson, R.A. and Sapolsky, R.M., glucocorticoids exacerbate hypoxic and hypogtycemia hippocampal injury in vitro: biochemical correlates and a role for astrocytes, J. Neurochem., 59 (1992) 137-142.
26. [26] Van Duijn, C.M. and Hofman, A., Relation between nicotine intake and Alzheimer's disease, Br. Med. J., 302 (1991) 1491-1494.
27. [27] Virgin Jr., C.E., Ha, T.T.-P., Packan, D.R., Tombaugh, G.C., Yang, S.H., Horner, H.C. and Sapolsky, R.M., Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity, J. Neurochem., 57 (1991) 1422-1428.